oseltamivir has been researched along with Community Acquired Infection in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Aldhahri, FA; Alghanem, AF; Althemery, AU | 1 |
| Charernmak, B; Chusri, S; Hortiwakul, T; Kanchanasuwan, S; Kositpantawong, N; Nwabor, OF; Siripaitoon, P; Surasombatpattana, S | 1 |
| Deshpande, A; Haessler, S; Higgins, T; Imrey, PB; Klompas, M; Lindenauer, PK; Pallotta, AM; Rothberg, MB; Yu, PC; Zilberberg, MD | 1 |
| Arabi, YM; Fowler, R; Hayden, FG | 1 |
| Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A | 1 |
| Abdalla, MI; Aliberti, S; Blasi, F; Di Pasquale, MF; Gramegna, A; Jankovic, M; Mahesh, PA; Marcos, PJ; Radovanovic, D; Restrepo, MI; Reyes, LF; Santus, P; Sotgiu, G; Terraneo, S | 1 |
| Bhadelia, N; Furuya, EY; Jia, H; McCarthy, JW; Saiman, L; Sonti, R; Vorenkamp, J | 1 |
| Booy, R; Dixit, R; Dwyer, D; Hay, P; Heron, L; Khandaker, G; McPhie, K; Rashid, H; Taylor, J | 1 |
| Chochlakis, D; Damianaki, A; Pasparaki, E; Psaroulaki, A | 1 |
| Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
| Hibino, A; Kondo, H; Masaki, H; Saito, R; Saito, T; Sato, I; Takemae, N; Tanabe, Y; Zaraket, H | 1 |
| Coffin, SE; Desai, B; Hodinka, RL; Keren, R; Leckerman, KH; Metjian, TA; Wilkes, JJ; Zaoutis, TE | 1 |
| Bots, J; Faidherbe, MT; Gerard, C; Gutiérrez, I; Hammadi, S; Litzroth, A; Robesyn, E; Van Oyen, H; Wuillaume, F | 1 |
| Adalja, A | 1 |
| Engelhard, D; Glikman, D; Hindiyeh, M; Mandelboim, M; Mendelson, E; Ram, D; Zonis, Z | 1 |
| Abdelrahman, M; AlOyouni, W; Jasim, MR; Karkar, A | 1 |
| Guo, AM; Kong, XC; Peng, WH; Song, HJ; Wang, P; Xiao, Q; Xing, SL; Zhu, ML | 1 |
| Bridger, NA; Bullard, JM; Coombs, JM; Crockett, ME; Embree, JE; Fanella, ST; Olekson, KL; Pinto, MA; Poliquin, PG; Van Caeseele, PG | 1 |
| Deng, YM; Gehrig, N; Hardie, K; Hurt, AC; Kelso, A; Osbourn, M; Wilson, NJ | 1 |
| Barr, IG; Booy, R; Caldwell, N; Dalton, C; Deng, YM; Dixit, R; Durrheim, D; Dwyer, DE; Gehrig, N; Givney, RC; Hardie, K; Hurt, AC; Iannello, P; Kelso, A; Leang, SK; Lee, RT; Levy, A; Maurer-Stroh, S; Merritt, T; Osbourn, M; Shaw, R; Smith, DW; Wang, B; Wark, P; Wilson, NJ; Xue, L | 1 |
| Booy, R; Dixit, R; Dwyer, DE; Hurt, A; Kesson, A; McPhie, K; Ratnamohan, M; Saksena, N; Taylor, J; Wang, B | 1 |
| Asgeirsson, H; Baldursson, O; Bjarnason, A; Gottfredsson, M; Gudnason, JF; Hallgrimsson, KL; Haraldsson, G; Kristinsson, KG; Kristjansdottir, BS; Löve, A; Thorleifsdottir, G | 1 |
| Dwyer, DE; Emery, S; Harrod, ME | 1 |
3 review(s) available for oseltamivir and Community Acquired Infection
| Article | Year |
|---|---|
Critical care management of adults with community-acquired severe respiratory viral infection.
Topics: Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Antivirals in the management of an influenza pandemic.
Topics: Amantadine; Antiviral Agents; Australia; Community-Acquired Infections; Disease Outbreaks; Drug Resistance, Viral; Government Programs; Humans; Infection Control; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; World Health Organization; Zanamivir | 2006 |
1 trial(s) available for oseltamivir and Community Acquired Infection
| Article | Year |
|---|---|
A randomized study of standard versus double dose oseltamivir for treating influenza in the community.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Patient Compliance; Treatment Outcome; Viral Load; Young Adult | 2015 |
19 other study(ies) available for oseltamivir and Community Acquired Infection
| Article | Year |
|---|---|
Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.
Topics: Community-Acquired Infections; Humans; Influenza, Human; Oseltamivir; Pneumonia; Retrospective Studies | 2021 |
Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.
Topics: Adult; Aged; Cohort Studies; Community-Acquired Infections; Female; Hospitalization; Humans; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Pneumonia, Viral; Retrospective Studies; Thailand; Treatment Outcome | 2021 |
Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Community-Acquired Infections; Hospitalization; Humans; Influenza, Human; Oseltamivir; Pneumonia; Retrospective Studies | 2022 |
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae | 2020 |
An international perspective on hospitalized patients with viral community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Community-Acquired Infections; Cross-Sectional Studies; Databases, Factual; Female; Hospitalization; Humans; Influenza, Human; Internationality; Logistic Models; Male; Medication Adherence; Middle Aged; Oseltamivir; Pneumonia, Viral; Prospective Studies | 2019 |
Impact of the 2009 influenza A (H1N1) pandemic on healthcare workers at a tertiary care center in New York City.
Topics: Adult; Aged; Algorithms; Antiviral Agents; Community-Acquired Infections; Cross Infection; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; New York City; Occupational Diseases; Occupational Exposure; Oseltamivir; Pandemics; Personnel, Hospital; Retrospective Studies; Sick Leave; Tertiary Care Centers; Young Adult | 2013 |
Severe community acquired pneumonia due to Legionella maceachernii infection.
Topics: Adult; Anti-Bacterial Agents; Bronchodilator Agents; Combined Modality Therapy; Community-Acquired Infections; Continuous Positive Airway Pressure; Humans; Legionella; Legionellosis; Male; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Bacterial; Radiography | 2015 |
Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan.
Topics: Acids, Carbocyclic; Adolescent; Adult; Aged; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cyclopentanes; Drug Resistance, Viral; Female; Genes, Viral; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Japan; Male; Middle Aged; Mutation; Oseltamivir; Phylogeny; Seasons; Young Adult | 2017 |
Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Community-Acquired Infections; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Oseltamivir; Practice Patterns, Physicians'; Reminder Systems; Retrospective Studies | 2009 |
Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009.
Topics: Adult; Anniversaries and Special Events; Antibiotic Prophylaxis; Antiviral Agents; Belgium; Community-Acquired Infections; Contact Tracing; Disease Outbreaks; Female; Humans; Infection Control; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Population Surveillance; Travel; Young Adult | 2009 |
Optimization of antiviral prescribing for influenza.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Community-Acquired Infections; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Oseltamivir; Practice Patterns, Physicians'; Reminder Systems | 2009 |
Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child, Israel.
Topics: Accidents, Traffic; Antiviral Agents; Child, Preschool; Community-Acquired Infections; Contusions; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Israel; Lung Injury; Male; Oseltamivir; Respiratory Distress Syndrome; Time Factors | 2010 |
H1N1 in dialysis units: prevention and management.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Community-Acquired Infections; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Renal Dialysis | 2010 |
[The clinical characteristics and treatment of community outbreaks of the new influenza A (H1N1) infection].
Topics: Adolescent; Adult; Antiviral Agents; Community-Acquired Infections; Drugs, Chinese Herbal; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Medicine, Chinese Traditional; Oseltamivir; Phytotherapy; Treatment Outcome; Young Adult | 2010 |
Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infection Control; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Length of Stay; Male; Manitoba; Oseltamivir; Pandemics; Retrospective Studies; Risk Factors; Seasons | 2011 |
Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza.
Topics: Community-Acquired Infections; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; New South Wales; Oseltamivir | 2011 |
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.
Topics: Adolescent; Adult; Antiviral Agents; Australia; Base Sequence; Child; Child, Preschool; Community-Acquired Infections; Disease Outbreaks; DNA, Viral; Drug Resistance, Viral; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Molecular Sequence Data; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Sequence Alignment; Young Adult | 2012 |
Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
Topics: Adult; Antiviral Agents; Australia; Base Sequence; Community-Acquired Infections; Disease Outbreaks; DNA Viruses; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Mutation; Neuraminidase; Oseltamivir; Polymerase Chain Reaction; Prevalence; RNA, Viral; Sequence Analysis, DNA | 2012 |
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Coinfection; Community-Acquired Infections; Comorbidity; Female; Humans; Iceland; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Middle Aged; Mycoplasma pneumoniae; Oseltamivir; Pandemics; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Streptococcus pneumoniae | 2012 |